Log in to search using one of your social media accounts:

 

Johannes Joseph van Rood Pioneer in immuno-genetics (7 April 1926–21 July 2017)
Johannes Joseph van Rood Pioneer in immuno-genetics (7 April 1926–21 July 2017)Leukemia, Published online: 1 October 2017; doi:10.1038/leu.2017.278 (Source: Leukemia)
Source: Leukemia - September 22, 2017 Category: Hematology Authors: W Fibbe R P Gale Source Type: research

Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2
Leukemia, Published online: 22 September 2017; doi:10.1038/leu.2017.298 (Source: Leukemia)
Source: Leukemia - September 22, 2017 Category: Hematology Authors: S Bartels M Faisal G B üsche J Schlue H Kreipe U Lehmann Source Type: research

Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis
Leukemia, Published online: 22 September 2017; doi:10.1038/leu.2017.297 (Source: Leukemia)
Source: Leukemia - September 22, 2017 Category: Hematology Authors: J-C Hern ández-Boluda A Pereira J-G Correa A Alvarez-Larr án F Ferrer-Mar ín J-M Raya J Mart ínez-López M P érez-Encinas N Estrada P Velez M-L Fox V Garc ía-Gutiérrez A Payer A Kerguelen B Cuevas M-A Dur án M-J Ram írez M-T G ómez-Casares M-I M Source Type: research

NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: Link between the NOTCH1 and the NF-kB pathways
Leukemia, Published online: 22 September 2017; doi:10.1038/leu.2017.296 (Source: Leukemia)
Source: Leukemia - September 22, 2017 Category: Hematology Authors: D Benedetti E Tissino F Pozzo T Bittolo C Caldana C Perini D Martorelli V Bravin T D ’Agaro F M Rossi R Bomben E Santinelli F Zaja G Pozzato A Chiarenza F Di Raimondo G Del Poeta D Rossi G Gaidano M Dal Bo V Gattei A Zucchetto Source Type: research

Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms
Leukemia, Published online: 22 September 2017; doi:10.1038/leu.2017.295 (Source: Leukemia)
Source: Leukemia - September 22, 2017 Category: Hematology Authors: S K Balasubramanian M Aly Y Nagata T Bat B P Przychodzen C M Hirsch V Adema V Visconte T Kuzmanovic T Radivoyevitch A Nazha S Mukherjee M A Sekeres J P Maciejewski Source Type: research

Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes
i & M A Sekeres (Source: Leukemia)
Source: Leukemia - September 19, 2017 Category: Hematology Authors: A Nazha K Al-Issa B K Hamilton T Radivoyevitch A T Gerds S Mukherjee V Adema A Zarzour N Abuhadra B J Patel C M Hirsch A Advani B Przychodzen H E Carraway J P Maciejewski M A Sekeres Source Type: research

Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib
; T O’Hare (Source: Leukemia)
Source: Leukemia - September 19, 2017 Category: Hematology Authors: W Qiang O Antelope M S Zabriskie A D Pomicter N A Vellore P Szankasi D Rea J M Cayuela T W Kelley M W Deininger T O ’ Hare Source Type: research

14-3-3ζ binds the proteasome, limits proteolytic function, and enhances sensitivity to proteasome inhibitors
14-3-3ζ binds the proteasome, limits proteolytic function, and enhances sensitivity to proteasome inhibitorsLeukemia, Published online: 19 September 2017; doi:10.1038/leu.2017.288 (Source: Leukemia)
Source: Leukemia - September 19, 2017 Category: Hematology Authors: Y Gu K Xu C Torre M Samur B G Barwick M Rupji J Arora P Neri J Kaufman A Nooka L Bernal-Mizrachi P Vertino S-Y Sun J Chen N Munshi H Fu J Kowalski L H Boise S Lonial Source Type: research

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
Leukemia, Published online: 19 September 2017; doi:10.1038/leu.2017.291 (Source: Leukemia)
Source: Leukemia - September 19, 2017 Category: Hematology Authors: F Nadeu G Clot J Delgado D Mart ín-García T Baumann I Salaverria S Be à M Pinyol P Jares A Navarro H Su árez-Cisneros M Aymerich M Rozman N Villamor D Colomer M Gonz ález M Alcoceba M J Terol B Navarro E Colado ÁR Payer X S Puente C L ópez-Otín A Source Type: research

Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia
Leukemia, Published online: 19 September 2017; doi:10.1038/leu.2017.290 (Source: Leukemia)
Source: Leukemia - September 19, 2017 Category: Hematology Authors: S Jo J H Lee J J Mattei D M Barrett S A Grupp G S D Reid A E Seif Source Type: research

A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies
A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodiesLeukemia, Published online: 19 September 2017; doi:10.1038/leu.2017.293 (Source: Leukemia)
Source: Leukemia - September 19, 2017 Category: Hematology Authors: E Casey S Bournazos G Mo P Mondello K S Tan J V Ravetch D A Scheinberg Source Type: research

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukemia: Results of the EORTC CLG 58881 and 58951 trials
Leukemia, Published online: 19 September 2017; doi:10.1038/leu.2017.289 (Source: Leukemia)
Source: Leukemia - September 19, 2017 Category: Hematology Authors: C Piette S Suciu E Clappier Y Bertrand S Drunat S Girard K Yakouben G Plat N Dastugue F Mazingue N Grardel N van Roy A Uyttebroeck V Costa O Minckes N Sirvent P Simon P Lutz A Ferster C Pluchart M Poir ée C Freycon M-F Dresse F Millot C Chantrain J van d Source Type: research

Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low and very-low risk genetic profile
Leukemia, Published online: 19 September 2017; doi:10.1038/leu.2017.292 (Source: Leukemia)
Source: Leukemia - September 19, 2017 Category: Hematology Authors: I Del Giudice G M Rigolin S Raponi L Cafforio C Ilari W Jiguang M Bordyuh A Piciocchi M Marinelli M Nanni S Tavolaro M Filetti A Bardi E Tammiso E Volta M Negrini E Saccenti F R Mauro D Rossi G Gaidano A Guarini R Rabadan A Cuneo R Fo à Source Type: research

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains
Leukemia, Published online: 18 September 2017; doi:10.1038/leu.2017.286 (Source: Leukemia)
Source: Leukemia - September 18, 2017 Category: Hematology Authors: S Sidana N Tandon A Dispenzieri M A Gertz F K Buadi M Q Lacy D Dingli A L Fonder S R Hayman M A Hobbs W I Gonsalves Y L Hwa P Kapoor R A Kyle N Leung R S Go J A Lust S J Russell S R Zeldenrust V Rajkumar S K Kumar Source Type: research

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
Leukemia, Published online: 18 September 2017; doi:10.1038/leu.2017.285 (Source: Leukemia)
Source: Leukemia - September 18, 2017 Category: Hematology Authors: P Boddu J Jorgensen H Kantarjian G Borthakur T Kadia N Daver Y Alvarado N Pemmaraju P Bose K Naqvi M Yilmaz S Pierce M Brandt C D DiNardo E J Jabbour M Konopleva G Garcia-Manero J Cortes F Ravandi Source Type: research

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia
Leukemia, Published online: 15 September 2017; doi:10.1038/leu.2017.284 (Source: Leukemia)
Source: Leukemia - September 15, 2017 Category: Hematology Authors: M-A Hospital A Jacquel F Mazed E Saland C Larrue J Mondesir R Birsen A S Green M Lambert P Sujobert E-F Gautier V Salnot M Le Gall J Decroocq L Poulain N Jacque M Fontenay O Kosmider C R écher P Auberger P Mayeux D Bouscary J-E Sarry J Tamburini Source Type: research

High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: A phase III study by JALSG
Leukemia, Published online: 15 September 2017; doi:10.1038/leu.2017.283 (Source: Leukemia)
Source: Leukemia - September 15, 2017 Category: Hematology Authors: T Sakura F Hayakawa I Sugiura T Murayama K Imai N Usui S Fujisawa T Yamauchi T Yujiri K Kakihana Y Ito H Kanamori Y Ueda Y Miyata M Kurokawa N Asou K Ohnishi S Ohtake Y Kobayashi K Matsuo H Kiyoi Y Miyazaki T Naoe Source Type: research

Epigenetic targeting of Notch1 driven transcription using the HDACi panobinostat is a potential therapy against T cell acute lymphoblastic leukemia
Leukemia, Published online: 15 September 2017; doi:10.1038/leu.2017.282 (Source: Leukemia)
Source: Leukemia - September 15, 2017 Category: Hematology Authors: M Waibel S J Vervoort I Y Kong S Heinzel K M Ramsbottom B P Martin E D Hawkins R W Johnstone Source Type: research

Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy
S T Nawrocki (Source: Leukemia)
Source: Leukemia - September 15, 2017 Category: Hematology Authors: K R Kelly C M Espitia W Zhao K Wu V Visconte F Anwer C M Calton J S Carew S T Nawrocki Source Type: research

Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA as compared with BM
M Albitar (Source: Leukemia)
Source: Leukemia - September 15, 2017 Category: Hematology Authors: A Albitar D Townsley W Ma I De Dios V Funari N S Young M Albitar Source Type: research

RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo
say, P Cullis & M Heuser (Source: Leukemia)
Source: Leukemia - September 15, 2017 Category: Hematology Authors: N Jyotsana A Sharma A Chaturvedi M Scherr F Kuchenbauer L Sajti A Barchanski R Lindner F Noyan K-W S ü hs D Grote-Koska K Brand H-P Vornlocher M Stanulla B Bornhauser J-P Bourquin M Eder F Thol A Ganser R K Humphries E Ramsay P Cullis M Heuser Source Type: research

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group
M Bentz, B Emmerich, H Döhner, M Hallek & S Stilgenbauer (Source: Leukemia)
Source: Leukemia - September 15, 2017 Category: Hematology Authors: M A Hoechstetter R Busch B Eichhorst A B ü hler D Winkler M J Eckart U Vehling-Kaiser H Schimke U J ä ger H J Hurtz G Hopfinger F Hartmann H Fuss W Abenhardt I Blau W Freier L M ü ller M Goebeler C M Wendtner J Bahlo K Fischer M Bentz B Emmerich H D ö Source Type: research

Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia
Leukemia, Published online: 14 September 2017; doi:10.1038/leu.2017.281 (Source: Leukemia)
Source: Leukemia - September 14, 2017 Category: Hematology Authors: S Takao W Chien V Madan D-C Lin L-W Ding Q-Y Sun A Mayakonda M Sudo L Xu Y Chen Y-Y Jiang S Gery M Lill E Park W Senapedis E Baloglu M M üschen H P Koeffler Source Type: research

Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
N Gangat (Source: Leukemia)
Source: Leukemia - September 12, 2017 Category: Hematology Authors: A Tefferi L Saeed C A Hanson R P Ketterling A Pardanani N Gangat Source Type: research

Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis
L Illert & G Scita (Source: Leukemia)
Source: Leukemia - September 12, 2017 Category: Hematology Authors: S Gerboth E Frittoli A Palamidessi F C Baltanas M Salek J Rappsilber C Giuliani F Troglio Y Rolland G Pruneri S Kreutmair I Pallavicini M Zobel M Cinquanta S Minucci C Gomez E Santos A L Illert G Scita Source Type: research

The C-terminal multimerization domain is essential for leukemia development by CBF β -SMMHC in a mouse knockin model
The C-terminal multimerization domain is essential for leukemia development by CBFβ-SMMHC in a mouse knockin model Leukemia advance online publication, September 12 2017. doi:10.1038/leu.2017.262 Authors: L Zhao, H Alkadi, E M Kwon, T Zhen, J Lichtenberg, L Alemu, J Cheng, A D Friedman & P P Liu (Source: Leukemia)
Source: Leukemia - September 12, 2017 Category: Hematology Authors: L Zhao H Alkadi E M Kwon T Zhen J Lichtenberg L Alemu J Cheng A D Friedman P P Liu Source Type: research

Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia
, M Subklewe & P A Greif (Source: Leukemia)
Source: Leukemia - September 12, 2017 Category: Hematology Authors: K Reiter H Polzer C Krupka A Maiser B Vick M Rothenberg-Thurley K H Metzeler D D ö rfel H R Salih G Jung E N ö ß ner I Jeremias W Hiddemann H Leonhardt K Spiekermann M Subklewe P A Greif Source Type: research

The expression of P2Y14, a purinergic G-protein coupled receptor, defines functionally distinct subpopulations in placenta-derived hematopoietic stem progenitor cells
B-C Lee (Source: Leukemia)
Source: Leukemia - September 12, 2017 Category: Hematology Authors: S-H Kook H-J Sim J-C Lee B-C Lee Source Type: research

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
enner, A Voskanyan, S Rinaldetti, W Seifarth, B Spieß, L Balleisen, M C Goebeler, M Hänel, A Ho, J Dengler, C Falge, L Kanz, S Kremers, A Burchert, M Kneba, F Stegelmann, C A Köhne, H W Lindemann, C F Waller, M Pfreundschuh, K Spiekermann, W E Berdel, L Müller, M Edinger, J Mayer, D W Beelen, M Bentz, H Link, B Hertenstein, R Fuchs, M Wernli, F Schlegel, R Schlag, M de Wit, L Trümper, H Hebart, M Hahn, J Thomalla, C Scheid, P Schafhausen, W Verbeek, M J Eckart, W Gassmann, A Pezzutto, M Schenk, P Brossart, T Geer, S Bildat, E Schäfer, A Hochhaus & J Hasford (Source: Leukemia)
Source: Leukemia - September 12, 2017 Category: Hematology Authors: R Hehlmann M Lauseker S Sau ß ele M Pfirrmann S Krause H J Kolb A Neubauer D K Hossfeld C Nerl A Gratwohl G M Baerlocher D Heim T H Br ü mmendorf A Fabarius C Haferlach B Schlegelberger M C M ü ller S Jeromin U Proetel K Kohlbrenner A Voskanyan S Rinal Source Type: research

Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed ?
Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed? Leukemia advance online publication, September 8 2017. doi:10.1038/leu.2017.263 Authors: Y Zhou, B L Wood, R B Walter, P S Becker, M-E Percival, M Bar, C Shaw, K Gardner, P Hendrie, J Abkowitz, F R Appelbaum & E Estey (Source: Leukemia)
Source: Leukemia - September 8, 2017 Category: Hematology Authors: Y Zhou B L Wood R B Walter P S Becker M-E Percival M Bar C Shaw K Gardner P Hendrie J Abkowitz F R Appelbaum E Estey Source Type: research

Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion
rcucci & C-C Chen (Source: Leukemia)
Source: Leukemia - September 8, 2017 Category: Hematology Authors: B Kumar M Garcia L Weng X Jung J L Murakami X Hu T McDonald A Lin A R Kumar D L DiGiusto A S Stein V A Pullarkat S K Hui N Carlesso Y-H Kuo R Bhatia G Marcucci C-C Chen Source Type: research

Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
irchmair & P Valent (Source: Leukemia)
Source: Leukemia - September 8, 2017 Category: Hematology Authors: E Hadzijusufovic K Albrecht-Schgoer K Huber G Hoermann F Grebien G Eisenwort W Schgoer S Herndlhofer C Kaun M Theurl W R Sperr U Rix I Sadovnik B Jilma G H Schernthaner J Wojta D Wolf G Superti-Furga R Kirchmair P Valent Source Type: research

Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse ?
Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse? Leukemia advance online publication, September 8 2017. doi:10.1038/leu.2017.238 Authors: A M Zeidan, M A Sekeres, J Barnard, D P Steensma & R Komrokji (Source: Leukemia)
Source: Leukemia - September 8, 2017 Category: Hematology Authors: A M Zeidan M A Sekeres J Barnard D P Steensma R Komrokji Source Type: research

High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis
ani & T Kitamura (Source: Leukemia)
Source: Leukemia - September 8, 2017 Category: Hematology Authors: K C Kawabata Y Hayashi D Inoue H Meguro H Sakurai T Fukuyama Y Tanaka S Asada T Fukushima R Nagase R Takeda Y Harada J Kitaura S Goyama H Harada H Aburatani T Kitamura Source Type: research

S1PR1 drives a feed forward signalling loop to regulate BATF3 and the transcriptional programme of hodgkin lymphoma cells
Leukemia, Published online: 7 September 2017; doi:10.1038/leu.2017.275 (Source: Leukemia)
Source: Leukemia - September 7, 2017 Category: Hematology Authors: K Vrzalikova M Ibrahim M Vockerodt T Perry S Margielewska L Lupino E Nagy E Soilleux D Liebelt R Hollows A Last G Reynolds M Abdullah H Curley M Care D Krappmann R Tooze J Allegood S Spiegel W Wei C B J Woodman P G Murray Source Type: research

Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality
amp; A Van den Broeke (Source: Leukemia)
Source: Leukemia - September 5, 2017 Category: Hematology Authors: M Artesi A Mar ç ais K Durkin N Rosewick V Hahaut F Suarez A Trinquand L Lhermitte V Asnafi V Avettand-Fenoel A Burny M Georges O Hermine A Van den Broeke Source Type: research

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
-Barca, L Escoda, H Miyoshi, K Ohshima, K Miyawaki, K Kato, K Akashi, A Mozos, L Colomo, M Alcoceba, A Valera, A Carrió, D Costa, N Lopez-Bigas, R Schmitz, L M Staudt, I Salaverria, A López-Guillermo & E Campo (Source: Leukemia)
Source: Leukemia - September 5, 2017 Category: Hematology Authors: K Karube A Enjuanes I Dlouhy P Jares D Martin-Garcia F Nadeu G R Ord ó ñ ez J Rovira G Clot C Royo A Navarro B Gonzalez-Farre A Vaghefi G Castellano C Rubio-Perez D Tamborero J Briones A Salar J M Sancho S Mercadal E Gonzalez-Barca L Escoda H Miyoshi K Source Type: research

SHP2 is required for BCR-ABL1-induced hematologic neoplasia
p; B G Neel (Source: Leukemia)
Source: Leukemia - September 5, 2017 Category: Hematology Authors: S Gu A Sayad G Chan W Yang Z Lu C Virtanen R A Van Etten B G Neel Source Type: research

C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation
Leukemia, Published online: 5 September 2017; doi:10.1038/leu.2017.280 (Source: Leukemia)
Source: Leukemia - September 5, 2017 Category: Hematology Authors: A E Marneth K H M Prange A S A Al Hinai S M Bergevoet N Tesi E Janssen-Megens B Kim N Sharifi M L Yaspo J Kuster M A Sanders E C G Stoetman J Knijnenburg T C J M Peters C M Zwaan H G Stunnenberg M M van den Heuvel-Eibrink T Haferlach M Fornerod J H Jansen Source Type: research

Lamin B1 regulates somatic mutations and progression of B-cell malignancies
ribben & A Braun (Source: Leukemia)
Source: Leukemia - September 1, 2017 Category: Hematology Authors: T Klymenko J Bloehdorn J Bahlo S Robrecht G Akylzhanova K Cox S Estenfelder J Wang J Edelmann J C Strefford T K Wojdacz K Fischer M Hallek S Stilgenbauer M Cragg J Gribben A Braun Source Type: research

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
Koschmieder, T H Brümmendorf, S Kytölä, E-R Savolainen, T Siitonen, P Ellonen, O Kallioniemi, K Wennerberg, W Ding, M-H Stern, W Huber, S Anders, J Tang, T Aittokallio, T Zenz, M Herling & S Mustjoki (Source: Leukemia)
Source: Leukemia - September 1, 2017 Category: Hematology Authors: E I Andersson S P ü tzer B Yadav O Dufva S Khan L He L Sellner A Schrader G Crispatzu M Ole ś H Zhang S Adnan-Awad S Lagstr ö m D Bellanger J P Mpindi S Eldfors T Pemovska P Pietarinen A Lauhio K Tomska C Cuesta-Mateos E Faber S Koschmieder T H Br ü m Source Type: research

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
ford & J H Lipton (Source: Leukemia)
Source: Leukemia - September 1, 2017 Category: Hematology Authors: T P Hughes B Leber F Cervantes N Spector R Pasquini N C D Clementino A P Schwarer P E Dorlhiac-Llacer F-X Mahon D Rea A Guerci-Bresler S Kamel-Reid I Bendit S Acharya T Glynos D Dalal S Branford J H Lipton Source Type: research

Phase I / II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) Leukemia advance online publication, September 1 2017. doi:10.1038/leu.2017.242 Authors: G Bug, A Burchert, E-M Wagner, N Kröger, T Berg, S Güller, S K Metzelder, A Wolf, S Hünecke, P Bader, J Schetelig, H Serve & O G Ottmann (Source: Leukemia)
Source: Leukemia - September 1, 2017 Category: Hematology Authors: G Bug A Burchert E-M Wagner N Kr ö ger T Berg S G ü ller S K Metzelder A Wolf S H ü necke P Bader J Schetelig H Serve O G Ottmann Source Type: research

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress
co & F Fazi (Source: Leukemia)
Source: Leukemia - September 1, 2017 Category: Hematology Authors: S Masciarelli E Capuano T Ottone M Divona S De Panfilis C Banella N I Noguera A Picardi G Fontemaggi G Blandino F Lo-Coco F Fazi Source Type: research

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial
Leukemia, Published online: 1 September 2017; doi:10.1038/leu.2017.258 (Source: Leukemia)
Source: Leukemia - September 1, 2017 Category: Hematology Authors: S Ailawadhi J R Mikhael B R LaPlant K M Laumann S Kumar V Roy D Dingli P L Bergsagel F K Buadi S V Rajkumar R Fonseca M A Gertz P Kapoor T Sher S R Hayman A K Stewart A Dispenzieri R A Kyle W I Gonsalves C B Reeder Y Lin R S Go N Leung T Kourelis J A Lust Source Type: research

Johannes Joseph van Rood Pioneer in immuno-genetics (April 7, 1926-July 21, 2017)
Leukemia, Published online: 1 September 2017; doi:10.1038/leu.2017.278 (Source: Leukemia)
Source: Leukemia - September 1, 2017 Category: Hematology Authors: W Fibbe R P Gale Source Type: research

Extracellular vesicles as potential biomarkers of acute graft-vs.-host-disease
Leukemia, Published online: 30 August 2017; doi:10.1038/leu.2017.277 (Source: Leukemia)
Source: Leukemia - August 30, 2017 Category: Hematology Authors: G Lia L Brunello S Bruno A Carpanetto P Omed è M Festuccia L Tosti E Maffini L Giaccone M Arpinati G Ciccone M Boccadoro A Evangelista G Camussi B Bruno Source Type: research

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
Leukemia, Published online: 30 August 2017; doi:10.1038/leu.2017.276 (Source: Leukemia)
Source: Leukemia - August 30, 2017 Category: Hematology Authors: S Degryse C E de Bock S Demeyer I Govaerts S Bornschein D Verbeke K Jacobs S Binos D A Skerrett-Byrne H C Murray N M Verrills P Van Vlierberghe J Cools M D Dun Source Type: research

Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation
es & M A Gertz (Source: Leukemia)
Source: Leukemia - August 29, 2017 Category: Hematology Authors: R Chakraborty E Muchtar S K Kumar F K Buadi D Dingli A Dispenzieri S R Hayman W J Hogan P Kapoor M Q Lacy N Leung R Warsame T Kourelis W Gonsalves M A Gertz Source Type: research

Influence of IDH on FLT3-ITD status in newly diagnosed AML
p; C D DiNardo (Source: Leukemia)
Source: Leukemia - August 29, 2017 Category: Hematology Authors: P Boddu K Takahashi N Pemmaraju N Daver C B Benton S Pierce M Konopleva F Ravandi J Cortes H Kantarjian C D DiNardo Source Type: research